NIH-GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue Reading NIH-GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

Natick Contracting Division – Ology Bioservices, COVID-19 Procurement Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue Reading Natick Contracting Division – Ology Bioservices, COVID-19 Procurement Agreement

BMGF – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue Reading BMGF – CureVac, Global Access Commitments Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue Reading CEPI – CureVac, Framework Partnering Agreement

Pfizer – Peru, COVID-19 Vaccine Binding Term Sheet

• Post author:GHIAA Editor
• Post published:June 28, 2021
• Post category:

Continue Reading Pfizer – Peru, COVID-19 Vaccine Binding Term Sheet

Pfizer/BioNTech-Dominican Republic Binding Term Sheet

• Post author:GHIAA Editor
• Post published:June 3, 2021
• Post category:

Continue Reading Pfizer/BioNTech-Dominican Republic Binding Term Sheet

Novavax– CEPI Outbreak Response to Novel Coronavirus (COVID-19) Funding Agreement

• Post author:GHIAA Editor
• Post published:May 19, 2021
• Post category:

Continue Reading Novavax– CEPI Outbreak Response to Novel Coronavirus (COVID-19) Funding Agreement

AstraZeneca – European Commission COVID-19 Vaccine Advance Purchase Agreement

• Post author:GHIAA Admin
• Post published:March 12, 2021
• Post category:

Continue Reading AstraZeneca – European Commission COVID-19 Vaccine Advance Purchase Agreement

CureVac – European Commission COVID-19 Vaccine Advance Purchase Agreement

• Post author:GHIAA Admin
• Post published:January 25, 2021
• Post category:

Continue Reading CureVac – European Commission COVID-19 Vaccine Advance Purchase Agreement